B41.7 Disseminated coccidioidomycosis
ICD-10 B41.7 is a billable code used to indicate a diagnosis of b41.7 disseminated coccidioidomycosis.
Disseminated coccidioidomycosis is a severe form of coccidioidomycosis, a fungal infection caused by the inhalation of spores from the Coccidioides species, primarily C. immitis and C. posadasii. This condition occurs when the infection spreads beyond the lungs to other parts of the body, including the skin, bones, joints, and central nervous system. Patients may present with a variety of symptoms, including fever, cough, chest pain, fatigue, and weight loss, along with systemic manifestations such as skin lesions or meningitis. The risk of dissemination is significantly higher in immunocompromised individuals, such as those with HIV/AIDS, cancer, or those on immunosuppressive therapy. Diagnosis typically involves serological tests, culture, or histopathological examination. Treatment often requires prolonged antifungal therapy, including agents such as fluconazole or amphotericin B, depending on the severity and location of the disease. Early recognition and appropriate management are crucial to improving patient outcomes.
Detailed clinical notes on the patient's history, physical examination findings, and laboratory results.
Patients presenting with respiratory symptoms and a history of travel to endemic areas.
Ensure documentation reflects the immunocompromised status and any comorbidities.
Pulmonary function tests, imaging studies, and treatment response documentation.
Patients with chronic cough and pulmonary nodules.
Document any respiratory failure or need for hospitalization.
Used to confirm diagnosis in suspected cases of disseminated coccidioidomycosis.
Document the reason for testing and clinical findings.
Infectious disease specialists should ensure comprehensive documentation of the patient's history.
Common symptoms include fever, cough, chest pain, fatigue, and systemic manifestations such as skin lesions or neurological symptoms.
Diagnosis is typically made through serological tests, cultures, and imaging studies that reveal the extent of the disease.
